- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
NIH Unleashes Mondo-Mega-Grants to Devour Disease
14 April 2009 3:02 pm
Scientists are racing to get their applications in for NIH's latest scheme for using the $10.4 billion it got in the stimulus bill—jumbo-sized Grand Opportunities, or GO, grants. It will spend $200 million on 2-year awards funded for $1 million or more—at least 35% larger than R01 grants, the mainstay of the NIH system.
Unlike NIH's other big stimulus competition, the Challenge Grants, which can be up to $1 million, the GO projects will require at least that much money. NIH wants to fund "high impact" short-term projects, which could mean answering a research question or creating infrastructure. That might entail validating disease biomarkers or using information technology to share radiology images across hospitals.
Many NIH institutes have listed specific projects they're interested in.
Johns Hopkins University molecular pathologist Anirban Maitra says the GO grants are "like a big sister" to the Challenge Grants; he suggests that only "the big guys" will try for them. Unlike the Challenge Grants, which could draw 10,000 applications, this competition won't generate an avalanche of proposals that have to be peer-reviewed. That's because grant seekers first have to send NIH a letter of intent (by 27 April), which NIH staff will use to pare down the possible proposals. The agency announced the GO competition on 23 March but for some reason only got around to issuing a press release today.